AMWL American Well

Amwell Announces Results for Second Quarter 2024

Amwell Announces Results for Second Quarter 2024

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at to view the second quarter 2024 earnings report.

The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio webcast at or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID number 7830032. A replay of the call will be available via webcast shortly after the completion of the call, at the same web link.

About Amwell

Amwell is a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit .  

©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation. 



Angela Vogen
Amwell
 

Sue Dooley
Amwell
4156029167
 
EN
31/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Well

 PRESS RELEASE

Amwell to Participate in Upcoming Investor Conferences

Amwell to Participate in Upcoming Investor Conferences Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September. Ido Schoenberg, M.D., Amwell’s chairman and CEO, and Robert Shepardson, Amwell’s CFO, will participate in the following conferences via fireside chat and one-on-one meetings held throughout the day: September 4, Morgan Stanley 22nd Annual Global Healthcare Conference in New York City; fireside chat at 1:50 p.m. ET. September 5, Wells Fargo Healthca...

 PRESS RELEASE

Amwell Announces Results for Second Quarter 2024

Amwell Announces Results for Second Quarter 2024 Boston, July 31, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at to view the second quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio webcast at or by dialing 1-888-510-2008 for U.S. particip...

 PRESS RELEASE

Amwell® to Report Second Quarter 2024 Operating Results

Amwell® to Report Second Quarter 2024 Operating Results Boston, July 17, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the of the company's website. Alternatively, participants can call (888) 510-2008...

 PRESS RELEASE

Amwell Announces Reverse Stock Split

Amwell Announces Reverse Stock Split Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stock are expected to begin trading on the New Yor...

 PRESS RELEASE

Amwell Announces Appointment of Ricky Goldwasser to its Board of Direc...

Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors Boston, June 17, 2024 (GLOBE NEWSWIRE) --  (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's , effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch